Upload
Featured Recent Articles Topics Login Upload

Search Results for 'P2y'

P2y published presentations and documents on DocSlides.

P2Y2
P2Y2
by giovanna-bartolotta
Agonist Promotes . Corneal . Epithelial Wou...
DUAL ANTIPLATELET THERAPY
DUAL ANTIPLATELET THERAPY
by mary
(DAPT) . BHAVI SHAH, DNP, APRN, ANP-C. UNIVERSITY ...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Fanaroff et al. JAMA Cardiol
Fanaroff et al. JAMA Cardiol
by alyssa
. 2020 . Background. Medication persistence . is ....
Management of Myocardial
Management of Myocardial
by clara
. infarction. . NSTEMI Guidelines. Benoit Lattuca...
Switching from dual antiplatelet therapy with aspirin plus a P2Y
Switching from dual antiplatelet therapy with aspirin plus a P2Y
by brown
12. inhibitor to dual pathway inhibition with asp...
Cangrelor : Friend or Foe? -
Cangrelor : Friend or Foe? -
by ariel
Cangrelor. : Not the CHAMPION We Hoped For. James ...
Aspirin in 2022: A New Aspirin for a New Chapter
Aspirin in 2022: A New Aspirin for a New Chapter
by belinda
March 28, 2022. Disclosures. Present Research/Gran...
Dominick J. Angiolillo
Dominick J. Angiolillo
by SunnySeahorse
, MD. , PhD. Professor. of Medicine. Medical Dire...
Antiplatelet Agents Mohammad Sistanizad
Antiplatelet Agents Mohammad Sistanizad
by blindnessinfluenced
Associate Professor of Clinical Pharmacy,. SBMU. C...
Prasugrel vs ticagrelor in acute coronary syndromes
Prasugrel vs ticagrelor in acute coronary syndromes
by tawny-fly
Giuseppe . Biondi-Zoccai. , MD. Sapienza Universi...
When should we start a
When should we start a
by myesha-ticknor
P2Y. 12. inhibitor . in patients with an acute c...
Novel antithrombotic agents in acute coronary syndromes: be
Novel antithrombotic agents in acute coronary syndromes: be
by jane-oiler
n . P2Y12 inhibitors. Giuseppe Biondi Zoccai. Sap...